References
- Hirasawa T, Gotoda T, Miyata S, Kato Y, Shimoda T, Taniguchi H, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer 2009;12:148-152. https://doi.org/10.1007/s10120-009-0515-x
- Youn HG, An JY, Choi MG, Noh JH, Sohn TS, Kim S. Recurrence after curative resection of early gastric cancer. Ann Surg Oncol 2010;17:448-454. https://doi.org/10.1245/s10434-009-0772-2
- Ishida M, Morita S, Saka M, Fukagawa T, Taniguchi H, Katai H. Metachronous liver metastasis from early gastric cancer. J Gastrointest Surg 2012;16:837-841. https://doi.org/10.1007/s11605-011-1800-7
- Saka M, Katai H, Fukagawa T, Nijjar R, Sano T. Recurrence in early gastric cancer with lymph node metastasis. Gastric Cancer 2008;11:214-218. https://doi.org/10.1007/s10120-008-0485-4
- Kodama Y, Inokuchi K, Soejima K, Matsusaka T, Okamura T. Growth patterns and prognosis in early gastric carcinoma. Superficially spreading and penetrating growth types. Cancer 1983;51:320-326. https://doi.org/10.1002/1097-0142(19830115)51:2<320::AID-CNCR2820510226>3.0.CO;2-#
- Sakamoto Y, Ohyama S, Yamamoto J, Yamada K, Seki M, Ohta K, et al. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 2003;133:507-511. https://doi.org/10.1067/msy.2003.147
- Yamamoto J, Sugihara K, Kosuge T, Takayama T, Shimada K, Yamasaki S, et al. Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg 1995;221:74-78. https://doi.org/10.1097/00000658-199501000-00009
- Kim SY, Kim HP, Kim YJ, Oh do Y, Im SA, Lee D, et al. Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin. Int J Oncol 2008;32:89-95.
- Dang HZ, Yu Y, Jiao SC. Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis. World J Gastroenterol 2012;18:2402-2407. https://doi.org/10.3748/wjg.v18.i19.2402
- Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al; ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastrooesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010;376:687-697. https://doi.org/10.1016/S0140-6736(10)61121-X
- Namikawa T, Shiga M, Ichikawa K, Kitagawa H, Kobayashi M, Hanazaki K. Metachronous liver and bone metastasis from small early gastric carcinoma without lymph node involvement: a case report. Mol Clin Oncol 2013;1:249-252. https://doi.org/10.3892/mco.2012.50
Cited by
- Potential Biomarkers in Diagnosis of Human Gastric Cancer vol.34, pp.3, 2015, https://doi.org/10.3109/07357907.2015.1114122